FindTrial
Sign In

Development of an Information Management Platform for Community Osteoporosis Clinics and Its Effect on Patient Medication Compliance

Development of an Information Management Platform for Community Osteoporosis Clinics and Its Effect on Patient Medication Compliance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110220
Enrollment
Unknown
Registered
2025-10-10
Start date
2025-04-09
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Observation group:None

Sponsors

Yue tan Community Health Service Center of Fu Xing Hospital-Affiliate of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with primary osteoporosis; 2. During the period from January 2021 to September 30, 2023, have had at least one prescription record for the target drug (alendronate or denosumab), with the date of the first prescription of the target drug considered as the start of the study.

Exclusion criteria

Exclusion criteria: 1. Patients with secondary osteoporosis; 2. Patients obtaining medication from multiple hospitals.

Design outcomes

Primary

MeasureTime frame
Medication adherence;—

Countries

China

Contacts

Public ContactYu Su

Yue tan Community Health Service Center of Fu Xing Hospital-Affiliate of Capital Medical University

fishcat_mimi@163.com+86 10 6801 7528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026